BGPT: Author Review: Oihana Iriondo

Fuel Your Discoveries

Quick Explanation Copied

Oihana Iriondo — scientific profile (from provided records): The visible publication footprint centers on cancer biology with emphasis on tumor heterogeneity, metastasis, and hypoxia/stress responses, including mechanistic studies and translationally oriented assays.

Strength appears most credible where multiple independent, citable works target distinct but connected biological mechanisms (e.g., SOX2–tamoxifen resistance; hypoxia-driven stem/progenitor expansion; CTC-based metastasis tropism; Tumor microenvironment autocrine signaling), but a rigorous assessment of experimental rigor requires access to full methods/controls for each paper.

Long Explanation

Author Review: Oihana Iriondo

Skeptical, evidence-weighted critique based only on the papers/DOIs explicitly provided.

Epistemic stance: Known vs inferred vs uncertain will be clearly separated.

Visual knowledge map (from provided works)

1) Evidence surface (what is known from the provided records)

Therapy resistance / cancer stem/progenitor links are represented by work on SOX2 promoting tamoxifen resistance in breast cancer cells.
Hypoxia-driven selection/expansion is reflected in work showing distinct breast stem/progenitor populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions.
Metastasis tropism and CTC biology is represented by work where circulating tumor cells (CTCs) exhibit metastatic tropism and reveal brain metastasis drivers.
Microenvironment-driven autocrine signaling in TNBC lung metastasis is represented by work on TAK1-mediated microenvironment-triggered autocrine signals.
Single-cell CTC detection/retrieval methodology is represented by an integrated assay for detection and retrieval of single viable CTCs.
Hypoxic memory and interferon suppression is represented by work on hypoxic memory mediating prolonged tumor-intrinsic type I interferon suppression.
Epigenetic/transcriptional regulation includes work on UTX in retinoic acid receptor-mediated gene regulation in leukemia (HOX-linked recruitment/demethylation described in the abstract-level record).
Neutrophils/innate immune contributions to metastasis are reflected in a Developmental Cell report/letter describing neutrophils helping tumor cells en route to metastasis.
Ex vivo CTC growth/expansion under stress is represented by work on N-acetyl-L-cysteine promoting ex vivo growth and expansion of single CTCs by mitigating stress responses.

2) Scientific strength assessment (known → inferred → uncertain)

Known (from provided DOIs/titles/abstract-level records):

The portfolio spans endocrine-therapy resistance (SOX2–tamoxifen), microenvironment/hypoxia biology (HIF1α/PHD3; hypoxic memory/IFN suppression), and metastasis-relevant CTC biology (CTC tropism; CTC assay development; ex vivo CTC expansion).
Several works are mechanistically framed (e.g., epigenetic regulation via UTX/HOX recruitment; TAK1 autocrine signaling), rather than purely descriptive.

Inferred (how this typically maps to scientific competence—but still uncertain without methods/results):

A recurring focus on stress microenvironments (hypoxia) plus heterogeneity (stem/progenitor subsets) is consistent with experience in experimentally and computationally complex cancer biology.
Inclusion of CTC single-cell retrieval/growth work suggests comfort with experimental handling constraints for rare-cell biology.

Uncertain / must be verified (major blind spot):

Experimental rigor details (randomization/blinding, number of replicates, controls, orthogonal validation, statistical power) cannot be evaluated from the provided excerpt-level information.
Authorship role (first/middle/last author contribution) is not fully resolved for every citation in the dataset provided here.
Some records are letters (e.g., neutrophils/metastatic transit) where the evidence base may be narrower than for full articles; evidence strength is therefore treated conservatively.

3) Cross-paper coherence check (skeptical synthesis)

A coherent mechanistic axis is plausible: hypoxia/stress programs can couple to immune signaling suppression (type I interferon) and to selection/expansion of stem/progenitor-like states, which in turn can affect therapy response and metastasis.
Methodological axis: CTC work suggests an emphasis on connecting cellular subpopulations to clinically relevant dissemination patterns.

Confidence is moderate: the thematic coherence is supported by the titles/abstract-level records, but the causal integration between mechanisms would require reading the full experimental details of each paper.

4) What could weaken the inference? (specific failure modes)

Overgeneralization across models: Cancer mechanisms can differ across cell lines, patient subtypes, and in vivo contexts; without full paper-level model descriptions, cross-study generality is uncertain.
Single-study causal claims: Mechanistic conclusions (e.g., autocrine signaling via TAK1; hypoxia-memory effects) depend on control adequacy and orthogonal perturbations; abstract-level information cannot confirm robustness.
Evidence strength variation by article type: Letters/short reports may include fewer experiments or abbreviated validation relative to full articles.

Feedback:

Updated: March 30, 2026